Retraction: Exosome component 4 promotes epithelial ovarian cancer cell proliferation, migration, and invasion via the Wnt pathway - Scorecard - MDSpire

Retraction: Exosome component 4 promotes epithelial ovarian cancer cell proliferation, migration, and invasion via the Wnt pathway

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: Withdrawal of Study: Exosome Component 4 Enhances Proliferation, Migration, and Invasion of Epithelial Ovarian Cancer Cells Through the Wnt Signaling Pathway

At a Glance

CategoryDetail
ConditionEpithelial Ovarian Cancer (EOC)
Key MechanismsWnt signaling pathway
Target PopulationPatients with epithelial ovarian cancer
Care SettingOncology

Key Highlights

  • Article retracted due to image integrity concerns.
  • Image overlap identified in Figure 2A.
  • Authors failed to provide satisfactory explanation during investigation.
  • Retraction approved by Chief Editors of Frontiers in Oncology.
  • Communication regarding retraction recorded by the publisher.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified due to retraction.

          Not applicable due to retraction.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Retraction: Exosome component 4 promotes epithelial ovarian cancer cell proliferation, migration, and invasion via the Wnt pathway

            • June 1, 2026

            Related Content

            Early high-resolution immune profiles are associated with survival, relapse and graft-versus-host-disease after allogeneic hematopoietic cell transplantation

            Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection

            PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials